Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4330300 | Brain Research | 2008 | 10 Pages |
Abstract
Although meningiomas represent the most common class of tumors of the central nervous system, the molecular events underlying their genesis and development are still not well defined, and therapeutic approaches based on the genetics of these tumors are currently lacking. In the present study we have used the immunoblotting technique to show that the p16INK4A, Cdk6 and pRB proteins are differentially expressed in primary meningioma cells with 20-, 30- and 36-fold difference between the lowest and the highest levels of each protein, respectively. In addition, we present evidence that the level of the anti-apoptosis survivin protein is high in these benign tumors. Moreover, the annexin V-associated flow cytometry technique was used to show that 60% of meningioma cell cultures underwent apoptosis in response to both γ-rays and cisplatin, and 50% of these cells exhibited significant sensitivity to hydroxyurea. These agents triggered apoptosis through the mitochondrial pathway, by increasing the Bax/Bcl-2 ratio. Interestingly, the induction of apoptosis following radiation and cisplatin was significant in all cells that expressed low levels of p16INK4A, Cdk6 and pRB proteins. These data shed more light on the molecular biology of meningioma cells and suggest that survivin and proteins of the RB pathway could play a determinant role in the development and the treatment of meningiomas.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Huda H. Al-Khalaf, Boleslaw Lach, Ayman Allam, Maher Hassounah, Ahmed AlKhani, Nasser Elkum, Salman A. Alrokayan, Abdelilah Aboussekhra,